Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin- 1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action: Serotonin reuptake inhibition and 5-HT(1A) receptor antagonism

1. Oficialdegui, A.M.
2. Martinez, J.
3. Pérez, S.
4. Heras, B.
5. Irurzun, M.
6. Palop, J.A.
7. Tordera, R.
8. Lasheras, B.
9. Del Río, J.
10. Monge, A.